Steve Austin

4.9k total citations
70 papers, 1.8k citations indexed

About

Steve Austin is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Steve Austin has authored 70 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 18 papers in Genetics and 12 papers in Physiology. Recurrent topics in Steve Austin's work include Hemophilia Treatment and Research (26 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Platelet Disorders and Treatments (17 papers). Steve Austin is often cited by papers focused on Hemophilia Treatment and Research (26 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Platelet Disorders and Treatments (17 papers). Steve Austin collaborates with scholars based in United Kingdom, United States and France. Steve Austin's co-authors include P. G. Lunn, Lawrence T. Weaver, Tim Cole, R. G. Whitehead, A.M. Prentice, Abbey J. Hughes, Joseph Crameri, Michael C. Woodward, Arthur D. Goren and M. Elia and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Blood.

In The Last Decade

Steve Austin

67 papers receiving 1.7k citations

Peers

Countries citing papers authored by Steve Austin

Since Specialization

Citations

This map shows the geographic impact of Steve Austin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Austin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Austin more than expected).

Fields of papers citing papers by Steve Austin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Austin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Austin. The network helps show where Steve Austin may publish in the future.

Co-authorship network of co-authors of Steve Austin

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Austin. A scholar is included among the top collaborators of Steve Austin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Austin. Steve Austin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel 2024 ·Haemophilia ·Michael Laffan, Paul McLaughlin, Jayashree Motwani, Jayanthi Alamelu, Steve Austin, (unknown), Gerard Dolan, (unknown), Richard Gooding, John D. Grainger, Catherine Harrison, (unknown), Anne M. Kelly, (unknown), (unknown), David Stephensen, Kate Talks, (unknown), (unknown)	0
2	Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy 2022 ·Blood ·Andrew J. Doyle, Matthew Stubbs, Tina Dutt, Will Lester, Will Thomas, (unknown), (unknown), Tanya Cranfield, Quentin A. Hill, Amanda Clark, Catherine Bagot, Steve Austin, John‐Paul Westwood, Mari Thomas, Marie Scully	10
3	Seroprevalence to adeno‐associated virus type 6 in people with hemophilia B from a UK adult cohort 2022 ·Research and Practice in Thrombosis and Haemostasis ·Sara Boyce, (unknown), Savita Rangarajan, Nicola Curry, Catherine Bagot, Steve Austin, Michael Laffan, Sarah Mangles, Kandiah Chandrakumaran, (unknown)	6
4	Plasma‐derived factor X concentrate compassionate use for hereditary factor X deficiency: Long‐term safety and efficacy in a retrospective data‐collection study 2021 ·Research and Practice in Thrombosis and Haemostasis ·James N. Huang, Ri Liesner, Steve Austin, Kaan Kavaklı, (unknown)	5
5	Genotype analysis and identification of novel mutations in a multicentre cohort of patients with hereditary factor X deficiency 2018 ·Blood Coagulation & Fibrinolysis ·Michael Mitchell, Michael Gattens, Kaan Kavaklı, Ri Liesner, Jeanette Payne, (unknown), Steve Austin	7
6	Minimally Invasive Aortic Valve Replacement in a Patient With Severe Hemophilia A 2016 ·Journal of Cardiothoracic and Vascular Anesthesia ·Christos Chamos, Martin T. Yates, Steve Austin, Vinayak Bapat	5
7	Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: Updated Results from a Phase 1 and Phase 1/2 Extension Study in Patients without Inhibitors 2016 ·Blood ·Margaret V. Ragni, Pencho Georgiev, Tim Mant, Michael Desmond Creagh, Toshko Lissitchkov, David Bevan, Steve Austin, C. R. M. Hay, Inga Hegemann, Rashid Kazmi, Pratima Chowdary, Savita Rangarajan, Chang-Heok Soh, Akin Akinc, (unknown), (unknown), John Pasi	22
8	Subchondral haematoma 2016 ·Hämostaseologie ·Steve Austin, Diane Back, Rupert Wharton	3
9	Iron Incorporation and Post-Malaria Anaemia 2008 ·PLoS ONE ·Conor Doherty, Sharon E. Cox, (unknown), Steve Austin, David C. Hilmers, Steven A. Abrams, Andrew M. Prentice	45
10	The JAK2^V617F mutation and thrombosis 2008 ·British Journal of Haematology ·Steve Austin, Jonathan Lambert	42
11	Audit of the peri‐delivery use of unfractionated heparin in women on therapeutic low‐molecular weight heparin 2008 ·British Journal of Haematology ·John Lambert, Steve Austin, Donald Peebles, Hannah Cohen	5
12	Haematology and neurology 2006 ·Journal of Neurology Neurosurgery & Psychiatry ·Steve Austin, Hannah Cohen, N. A. Losseff	9
13	Recovery of pure red‐cell aplasia secondary to antierythropoietin antibodies after cessation of recombinant human erythropoietin 2003 ·Internal Medicine Journal ·Usha Panchapakesan, Steve Austin, (unknown), J. A. Lawrence, Elliott Savdie	4
14	Increased circulating normal and BCR-ABL+Ve progenitor numbers in Philadelphia chromosome-positive acute myeloid leukaemia 2002 ·Leukemia Research ·Paul Baines, Steve Austin, Janet Fisher, Eleri Owen-Jones, (unknown), (unknown), (unknown), Timothy J. Hoy, Ken Mills, Peter Thompson, Alan K. Burnett	2
15	Effects of Protein Restriction in Early Life on Growth and Function of the Gastrointestinal Tract of the Rat 1998 ·Journal of Pediatric Gastroenterology and Nutrition ·Lawrence T. Weaver, Mina Desai, Steve Austin, Helen M. Arthur, Alan Lucas, C. N. Hales	23
16	Response of parkinsonian swallowing dysfunction to dopaminergic stimulation 1997 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Joseph Crameri, Steve Austin, Michael C. Woodward, Abbey J. Hughes	141
17	A proposed intestinal mechanism for the effect of riboflavin deficiency on iron loss in the rat 1993 ·British Journal Of Nutrition ·Hilary J. Powers, Lawrence T. Weaver, Steve Austin, (unknown)	35
18	Small intestinal length: a factor essential for gut adaptation. 1991 ·Gut ·Lawrence T. Weaver, Steve Austin, Tim Cole	173
19	Riboflavin deficiency in the rat: effects on iron utilization and loss 1991 ·British Journal Of Nutrition ·(unknown), Lawrence T. Weaver, Steve Austin, A. J. Wright, Susan J. Fairweather‐Tait	39
20	Carbohydrate, fat, and protein metabolism in muscle and in the whole body after mixed meal ingestion 1988 ·Metabolism ·M. Elia, (unknown), (unknown), Arthur D. Goren, Steve Austin	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact